Barrington Research Has Lowered Expectations for DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price lowered by investment analysts at Barrington Research from $36.00 to $24.00 in a report released on Friday,Benzinga reports. The firm presently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research’s target price indicates a potential upside of 34.38% from the company’s previous close. Barrington Research also issued estimates for DENTSPLY SIRONA’s Q1 2025 earnings at $0.38 EPS, Q2 2025 earnings at $0.49 EPS, Q3 2025 earnings at $0.52 EPS, Q4 2025 earnings at $0.57 EPS and FY2025 earnings at $1.95 EPS.

Other equities analysts have also recently issued research reports about the company. Evercore ISI lowered their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Needham & Company LLC decreased their target price on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a report on Friday. Leerink Partners downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday. Finally, StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Wednesday. Six equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $29.50.

DENTSPLY SIRONA Stock Up 3.5 %

XRAY stock opened at $17.86 on Friday. The company has a market cap of $3.62 billion, a PE ratio of -8.63, a price-to-earnings-growth ratio of 1.31 and a beta of 1.02. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. DENTSPLY SIRONA has a 52 week low of $17.21 and a 52 week high of $37.60. The business has a 50-day simple moving average of $24.68 and a 200 day simple moving average of $25.86.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The business had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. During the same quarter last year, the business posted $0.49 EPS. The firm’s revenue for the quarter was up .4% on a year-over-year basis. Sell-side analysts anticipate that DENTSPLY SIRONA will post 1.98 EPS for the current fiscal year.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors have recently added to or reduced their stakes in XRAY. UMB Bank n.a. raised its stake in shares of DENTSPLY SIRONA by 430.3% during the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after acquiring an additional 753 shares during the last quarter. Capital Performance Advisors LLP acquired a new stake in DENTSPLY SIRONA in the third quarter valued at $27,000. LRI Investments LLC raised its position in DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after purchasing an additional 564 shares during the last quarter. Kennebec Savings Bank acquired a new position in DENTSPLY SIRONA during the 3rd quarter worth about $35,000. Finally, Rothschild Investment LLC bought a new stake in shares of DENTSPLY SIRONA in the 2nd quarter valued at about $32,000. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.